{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:21:36Z","timestamp":1790724096319,"version":"4.1.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1097\/sla.0b013e31827a0e82","type":"journal-article","created":{"date-parts":[[2012,12,5]],"date-time":"2012-12-05T21:13:19Z","timestamp":1354741999000},"page":"262-269","source":"Crossref","is-referenced-by-count":62,"title":["Pharmacokinetic and Pharmacodynamic Alterations in the Roux-en-Y Gastric Bypass Recipients"],"prefix":"10.1097","volume":"258","author":[{"given":"Sweta","family":"Tandra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naga","family":"Chalasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer","family":"Mattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Vuppalanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210203","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jamcollsurg.2008.08.022","article-title":"Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004.","volume":"207","author":"Nguyen","year":"2008","journal-title":"J Am Coll Surg"},{"key":"R2-10-20210203","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.23280","article-title":"Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications.","volume":"51","author":"Fabbrini","year":"2010","journal-title":"Hepatology"},{"key":"R3-10-20210203","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/hep.20323","article-title":"Portal fibrosis and hepatic steatosis in morbidly obese subjects: a spectrum of nonalcoholic fatty liver disease.","volume":"40","author":"Abrams","year":"2004","journal-title":"Hepatology"},{"key":"R4-10-20210203","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMoa066603","article-title":"Long-term mortality after gastric bypass surgery.","volume":"357","author":"Adams","year":"2007","journal-title":"N Engl J Med"},{"key":"R6-10-20210203","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1001\/jama.288.14.1723","article-title":"Prevalence and trends in obesity among US adults, 1999-2000.","volume":"288","author":"Flegal","year":"2002","journal-title":"JAMA"},{"key":"R7-10-20210203","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1053\/j.gastro.2006.01.042","article-title":"Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease.","volume":"130","author":"Klein","year":"2006","journal-title":"Gastroenterology"},{"key":"R8-10-20210203","doi-asserted-by":"crossref","first-page":"281","DOI":"10.7326\/0003-4819-155-5-201109060-00005","article-title":"Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch: a randomized trial.","volume":"155","author":"Sovik","year":"2011","journal-title":"Ann Intern Med"},{"key":"R9-10-20210203","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1744-1609.2009.00123.x","article-title":"Effects of bariatric surgery on morbidity and mortality in severe obesity.","volume":"7","author":"Chang","year":"2009","journal-title":"Int J Evid-Based Healthc"},{"key":"R10-10-20210203","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1001\/jama.292.14.1724","article-title":"Bariatric surgery: a systematic review and meta-analysis.","volume":"292","author":"Buchwald","year":"2004","journal-title":"JAMA"},{"key":"R11-10-20210203","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jamcollsurg.2011.04.030","article-title":"Trends in use of bariatric surgery, 2003-2008.","volume":"213","author":"Nguyen","year":"2011","journal-title":"J Am Coll Surg"},{"key":"R12-10-20210203","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1001\/jama.294.15.1909","article-title":"Trends in bariatric surgical procedures.","volume":"294","author":"Santry","year":"2005","journal-title":"JAMA"},{"key":"R13-10-20210203","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.gtc.2009.12.003","article-title":"Postoperative metabolic and nutritional complications of bariatric surgery.","volume":"39","author":"Koch","year":"2010","journal-title":"Gastroenterol Clin North Am"},{"key":"R14-10-20210203","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11695-009-9916-5","article-title":"Long-term nutritional outcome after gastric bypass.","volume":"20","author":"Dalcanale","year":"2010","journal-title":"Obes Surg"},{"key":"R15-10-20210203","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1530\/EJE-10-1126","article-title":"Vitamin D absorption: consequences of gastric bypass surgery.","volume":"164","author":"Aarts","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"R16-10-20210203","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/nrd1851","article-title":"Predicting in vivo drug interactions from in vitro drug discovery data.","volume":"4","author":"Wienkers","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"R17-10-20210203","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1172\/JCI113154","article-title":"Purification of a human liver cytochrome P-450 immunochemically related to several cytochromes P-450 purified from untreated rats.","volume":"80","author":"Wrighton","year":"1987","journal-title":"J Clin Invest"},{"key":"R18-10-20210203","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/j.1440-1681.2007.04691.x","article-title":"Expression of CYP3A isoforms and P-glycoprotein in human stomach, jejunum and ileum.","volume":"34","author":"Canaparo","year":"2007","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R19-10-20210203","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0022-3565(24)37149-6","article-title":"Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism.","volume":"283","author":"Paine","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"R20-10-20210203","first-page":"160","article-title":"Comparison of the pharmacokinetics and pharmacodynamics of torasemide and furosemide in healthy volunteers.","volume":"38","author":"Lesne","year":"1988","journal-title":"Arzneimittelforschung"},{"key":"R21-10-20210203","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0009-9236(95)90222-8","article-title":"Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure.","volume":"57","author":"Vargo","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"R22-10-20210203","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1365-2036.2010.04426.x","article-title":"The effects of midodrine on the natriuretic response to furosemide in cirrhotics with ascites.","volume":"32","author":"Misra","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"R23-10-20210203","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1067\/mcp.2000.109519","article-title":"Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the Cooperstown cocktail.","volume":"68","author":"Streetman","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"R24-10-20210203","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/sj.clpt.6100050","article-title":"Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the cocktail approach.","volume":"81","author":"Fuhr","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"R25-10-20210203","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1067\/mcp.2002.129068","article-title":"Application of semisimultaneous midazolam administration for hepatic and intestinal cytochrome P450 3A phenotyping.","volume":"72","author":"Lee","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"R26-10-20210203","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11095-004-9004-4","article-title":"Predicting drug disposition via application of BCS: transportabsorptionelimination interplay and development of a biopharmaceutics drug disposition classification system.","volume":"22","author":"Wu","year":"2005","journal-title":"Pharm Res"},{"key":"R27-10-20210203","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0090-9556(25)00282-X","article-title":"Absorption and disposition of furosemide in healthy volunteers, measured with a metabolite-specific assay.","volume":"8","author":"Smith","year":"1980","journal-title":"Drug Metab Dispos"},{"key":"R28-10-20210203","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/bdd.2510060202","article-title":"Pharmacokinetics of furosemide after three different single oral doses.","volume":"6","author":"Waller","year":"1985","journal-title":"Biopharm Drug Dispos"},{"key":"R29-10-20210203","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1681\/ASN.V1251010","article-title":"Effects of albuminfurosemide mixtures on responses to furosemide in hypoalbuminemic patients.","volume":"12","author":"Chalasani","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R30-10-20210203","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ki.1982.134","article-title":"The time course of delivery of furosemide into urine: an independent determinant of overall response.","volume":"22","author":"Kaojarern","year":"1982","journal-title":"Kidney Int"},{"key":"R31-10-20210203","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/ki.1979.120","article-title":"Pharmacodynamic analysis of the furosemide-probenecid interaction in man.","volume":"16","author":"Chennavasin","year":"1979","journal-title":"Kidney Int"},{"key":"R32-10-20210203","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.2146\/ajhp060033","article-title":"Medication and nutrient administration considerations after bariatric surgery.","volume":"63","author":"Miller","year":"2006","journal-title":"Am Health Syst Pharm"},{"key":"R33-10-20210203","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/0115426503018002131","article-title":"Altered drug disposition in obesity and after bariatric surgery.","volume":"18","author":"Malone","year":"2003","journal-title":"Nutr Clin Pract"},{"key":"R34-10-20210203","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2165\/00003088-199325020-00003","article-title":"Clinical pharmacokinetics of drugs in obesity. An update.","volume":"25","author":"Cheymol","year":"1993","journal-title":"Clin Pharmacokinet"},{"key":"R35-10-20210203","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1381\/096089296765557222","article-title":"Drug distribution in obesity and following bariatric surgery: a literature review.","volume":"6","author":"Macgregor","year":"1996","journal-title":"Obes Surg"},{"key":"R36-10-20210203","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/clpt.2009.82","article-title":"Significantly altered systemic exposure to atorvastatin acid following gastric bypass surgery in morbidly obese patients.","volume":"86","author":"Skottheim","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"R37-10-20210203","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.soard.2010.12.003","article-title":"Preliminary comparison of sertraline levels in postbariatric surgery patients versus matched nonsurgical cohort.","volume":"8","author":"Roerig","year":"2012","journal-title":"Surg Obes Relat Dis"},{"key":"R38-10-20210203","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1365-2125.2002.01698.x","article-title":"Faster absorption of ethanol and higher peak concentration in women after gastric bypass surgery.","volume":"54","author":"Klockhoff","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"R39-10-20210203","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.soard.2008.01.004","article-title":"Alcohol abuse and dependence before and after bariatric surgery: a review of the literature and report of a new data set.","volume":"4","author":"Ertelt","year":"2008","journal-title":"Surg Obes Relat Dis"},{"key":"R40-10-20210203","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jamcollsurg.2010.09.020","article-title":"Impaired alcohol metabolism after gastric bypass surgery: a case-crossover trial.","volume":"212","author":"Woodard","year":"2011","journal-title":"J Am Coll Surg"},{"key":"R41-10-20210203","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s11695-010-0177-0","article-title":"Narcotic addiction following gastric bypass surgerya case study.","volume":"21","author":"Wendling","year":"2011","journal-title":"Obes Surg"},{"key":"R42-10-20210203","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1211\/jpp.61.05.0002","article-title":"Cytochrome P450-mediated metabolism in the human gut wall.","volume":"61","author":"Thelen","year":"2009","journal-title":"J Pharm Pharmacol"},{"key":"R43-10-20210203","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1172\/JCI34007","article-title":"Gut instincts: CYP3A4 and intestinal drug metabolism.","volume":"117","author":"Thummel","year":"2007","journal-title":"J Clin Invest"},{"key":"R44-10-20210203","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.clpt.2003.10.008","article-title":"Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens.","volume":"75","author":"von Richter","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"R45-10-20210203","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJM197806222982505","article-title":"Intestinal adaptation (first of two parts). Structural, functional and cytokinetic changes.","volume":"298","author":"Williamson","year":"1978","journal-title":"New Engl J Med"},{"issue":"suppl","key":"R46-10-20210203","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/gut.28.Suppl.165","article-title":"Proximal enterectomy provides a stronger systemic stimulus to intestinal adaptation than distal enterectomy.","volume":"28","author":"Appleton","year":"1987","journal-title":"Gut"},{"key":"R47-10-20210203","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.jpedsurg.2010.02.036","article-title":"The influence of nutrients, biliary-pancreatic secretions, and systemic trophic hormones on intestinal adaptation in a Roux-en-Y bypass model.","volume":"45","author":"Taqi","year":"2010","journal-title":"J Pediatric Surg"},{"key":"R48-10-20210203","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.cgh.2006.12.021","article-title":"Association between nonalcoholic hepatic steatosis and hepatic cytochrome P-450 3A activity.","volume":"5","author":"Kolwankar","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R49-10-20210203","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.cgh.2008.08.012","article-title":"Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis.","volume":"6","author":"Mummadi","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R50-10-20210203","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1177\/0091270003254575","article-title":"Furosemide pharmacokinetics and pharmacodynamics following gastroretentive dosage form administration to healthy volunteers.","volume":"43","author":"Klausner","year":"2003","journal-title":"J Clin Pharmacol"},{"key":"R51-10-20210203","first-page":"381","article-title":"Furosemide (frusemide). A pharmacokineticpharmacodynamic review, part I.","volume":"18","author":"Ponto","year":"1990","journal-title":"Clin Pharmacokinet"}],"container-title":["Annals of Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00000658-201308000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T08:40:39Z","timestamp":1745397639000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000658-201308000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/sla.0b013e31827a0e82","relation":{},"ISSN":["0003-4932"],"issn-type":[{"value":"0003-4932","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}